首页> 美国卫生研究院文献>BMJ Open Access >CALLA: Efficacy and safety of concurrent and adjuvant durvalumab with chemoradiotherapy versus chemoradiotherapy alone in women with locally advanced cervical cancer: a phase III randomized double-blind multicenter study

【2h】

CALLA: Efficacy and safety of concurrent and adjuvant durvalumab with chemoradiotherapy versus chemoradiotherapy alone in women with locally advanced cervical cancer: a phase III randomized double-blind multicenter study

机译：Calla：同时和佐剂与疗效疗效与疗法疗法的疗效和安全性单独服用宫颈癌的妇女：III期随机双盲多中心研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

Background

著录项

期刊名称 BMJ Open Access
作者
Jyoti Mayadev; Ana T Nunes; Mary Li; Michelle Marcovitz; Mark C Lanasa; Bradley J Monk;
展开▼
作者单位

展开▼
年(卷),期 -1(30),7
年度 -1
页码 -1
总页数 6
原文格式 PDF
正文语种
中图分类
关键词
ureter; intestine; large; peritoneal neoplasms; pain; uterus;

相似文献

外文文献
中文文献
专利

1. Efficacy in high burden locally advanced cervical cancer with concurrent gemcitabine and cisplatin chemoradiotherapy plus adjuvant gemcitabine and cisplatin: Prognostic and predictive factors and the impact of disease stage on outcomes from a prospective randomized phase III trial [J] . Dueňas-GonzálezA., OrlandoM., ZhouY., Gynecologic Oncology: An International Journal . 2012,第3期

机译：吉西他滨联合顺铂放化疗联合吉西他滨和顺铂辅助化疗在高负荷局部晚期宫颈癌中的疗效：预后和预测因素以及疾病阶段对前瞻性随机III期临床结果的影响
2. Efficacy and safety of concurrent chemoradiotherapy in ECOG 2 patients with locally advanced non-small-cell lung cancer: a subgroup analysis of a randomized phase III trial [J] . Nan Bi, Lipin Liu, Jun Liang, BMC Cancer . 2020,第1期

机译：ECOG 2患者同时化疗的疗效和安全性局部晚期非小细胞肺癌的疗效和安全性：随机期III试验的亚组分析
3. Efficacy and Safety of Concurrent Chemoradiotherapy in ECOG 2 Patients with Locally Advanced Non-Small-Cell Lung Cancer: A Subgroup Analysis of a Randomized Phase III Trial [J] . Bi N., Liu L., Liang J., International Journal of Radiation Oncology, Biology, Physics . 2019,第1Suppla期

机译：ECOG 2患者同时化疗的疗效和安全性局部晚期非小细胞肺癌的疗效和安全性：随机期III试验的亚组分析
4. Efficacy and safety of concurrent chemoradiotherapy in ECOG 2 patients with locally advanced non-small-cell lung cancer: a subgroup analysis of a randomized phase III trial [O] . Nan Bi, Lipin Liu, Jun Liang, 2020

机译：ECOG 2局部晚期非小细胞肺癌患者同时放化疗的疗效和安全性：一项随机III期试验的亚组分析
5. CALLA: Efficacy and safety of concurrent and adjuvant durvalumab with chemoradiotherapy versus chemoradiotherapy alone in women with locally advanced cervical cancer: a phase III, randomized, double-blind, multicenter study [O] . Jyoti Mayadev, Ana T Nunes, Mary Li, 2020

机译：Calla：同时和佐剂与疗效疗效与疗法疗法的疗效和安全性，单独服用宫颈癌的妇女：III期，随机，双盲，多中心研究

CALLA: Efficacy and safety of concurrent and adjuvant durvalumab with chemoradiotherapy versus chemoradiotherapy alone in women with locally advanced cervical cancer: a phase III randomized double-blind multicenter study

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅